Drug Shortage Report for DOSTINEX
Report ID | 95815 |
Drug Identification Number | 02242471 |
Brand name | DOSTINEX |
Common or Proper name | Dostinex |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | CABERGOLINE |
Strength(s) | 0.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 8's |
ATC code | G02CB |
ATC description | OTHER GYNECOLOGICALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-10-08 |
Estimated end date | 2019-12-20 |
Actual end date | 2019-12-20 |
Shortage status | Resolved |
Updated date | 2019-12-21 |
Company comments | Distributed by Paladin. Limited inventory available and on preventative allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-10-09 | English | Compare |
v2 | 2019-10-09 | French | Compare |
v3 | 2019-12-20 | English | Compare |
v4 | 2019-12-20 | French | Compare |
v5 | 2019-12-21 | English | Compare |
Showing 1 to 5 of 5